Blood routine test in mild and common 2019 coronavirus (COVID-19) patients

Dodji Kossi Djakpo,Zhiquan Wang,Rong Zhang,Xin Chen,Peng Chen,Malyn Martha Lilac Ketisha Antoine,Dodji Kossi Djakpo,Malyn Martha Lilac Ketisha Antoine
DOI: https://doi.org/10.1042/bsr20200817
2020-08-01
Bioscience Reports
Abstract:Abstract The new 2019 coronavirus disease (COVID-19), according to the World Health Organization (WHO), has been characterized as a pandemic. As more is being discovered about this virus, we aim to report findings of the complete blood count (CBC) of COVID-19 patients. This would serve in providing physicians with important knowledge on the changes that can be expected from the CBC of mild and normal COVID-19 patients. A total of 208 mild and common patients were admitted at the Dongnan Hospital located in the city of Xiaogan, Hubei, China. The CBCs of these patients, following a confirmed diagnosis of COVID-19, were retrospectively analyzed and a significant P<0.05 was found after a full statistical analysis was conducted using the Statistical Package for the Social Sciences (IBM SPSS). CBC analysis revealed changes in the levels of red blood cells (RBCs), hemoglobin (HGB), hematocrit (HCT), mean corpuscular volume (MCV), and C-reactive protein (CRP). Clinicians should expect similar findings when dealing with the new COVID-19.
cell biology,biochemistry & molecular biology
What problem does this paper attempt to address?